| Dr Robert Augustus Jarrett, MD | |
|
789 Central Ave, Dover, NH 03820-2526 | |
| (603) 609-6819 | |
| (603) 609-6821 |
| Full Name | Dr Robert Augustus Jarrett |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 36 Years |
| Location | 789 Central Ave, Dover, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659318723 | NPI | - | NPPES |
| 1008160 | Medicaid | VT | |
| 3097836 | Medicaid | NH | |
| 000608517K | Medicaid | GA | |
| 000608517J | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 038260 (Georgia) | Secondary |
| 207L00000X | Anesthesiology | 11195 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wentworth-douglass Hospital | Dover, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wentworth Douglass Physician Corporation | 5496749848 | 372 |
News Archive
Scientists at Washington University School of Medicine in St. Louis have shown that a protein may help prevent the kind of brain damage that occurs in babies with cerebral palsy.
A team of Cedars-Sinai Heart Institute stem cell researchers led by Eduardo Marbán, M.D., Ph.D. has been awarded a four-year, $5.5 million grant from the California Institute of Regenerative Medicine (CIRM) to fund research leading to clinical trials of new treatments for heart attack patients.
Dendreon Corporation today announced that it has completed the submission of the post-approval supplement to the PROVENGE® (sipuleucel-T) Biologics License Application for the Morris Plains, New Jersey manufacturing facility. Dendreon is requesting licensure for an additional 36 workstations to manufacture PROVENGE. The standard U.S. Food and Drug Administration (FDA) review for a post-approval supplement to a Biologics License Application is typically four months.
To evaluate and understand the adherence to public health actions recommended by the government, a team in Norway undertook a study funded in part by the Norwegian Research Council's Centres of Excellence Funding Scheme and by the project: A realtime analytical pipeline for preparedness, planning, and response during the COVID-19 pandemic in Norway.
Can cancer patients tap into a certain kind of hope that is often overlooked but incredibly therapeutic and healing? Research by University Distinguished Professor of Marketing Leonard Berry of Texas A&M University's Mays Business School suggests clinicians can help patients tap into this kind of hope.
› Verified 3 days ago
| Entity Name | North American Partners In Anesthesia New Hampshire Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306838701 PECOS PAC ID: 6901710946 Enrollment ID: O20031114000273 |
News Archive
Scientists at Washington University School of Medicine in St. Louis have shown that a protein may help prevent the kind of brain damage that occurs in babies with cerebral palsy.
A team of Cedars-Sinai Heart Institute stem cell researchers led by Eduardo Marbán, M.D., Ph.D. has been awarded a four-year, $5.5 million grant from the California Institute of Regenerative Medicine (CIRM) to fund research leading to clinical trials of new treatments for heart attack patients.
Dendreon Corporation today announced that it has completed the submission of the post-approval supplement to the PROVENGE® (sipuleucel-T) Biologics License Application for the Morris Plains, New Jersey manufacturing facility. Dendreon is requesting licensure for an additional 36 workstations to manufacture PROVENGE. The standard U.S. Food and Drug Administration (FDA) review for a post-approval supplement to a Biologics License Application is typically four months.
To evaluate and understand the adherence to public health actions recommended by the government, a team in Norway undertook a study funded in part by the Norwegian Research Council's Centres of Excellence Funding Scheme and by the project: A realtime analytical pipeline for preparedness, planning, and response during the COVID-19 pandemic in Norway.
Can cancer patients tap into a certain kind of hope that is often overlooked but incredibly therapeutic and healing? Research by University Distinguished Professor of Marketing Leonard Berry of Texas A&M University's Mays Business School suggests clinicians can help patients tap into this kind of hope.
› Verified 3 days ago
| Entity Name | Anesthesia Care Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629074224 PECOS PAC ID: 5395646178 Enrollment ID: O20040115000446 |
News Archive
Scientists at Washington University School of Medicine in St. Louis have shown that a protein may help prevent the kind of brain damage that occurs in babies with cerebral palsy.
A team of Cedars-Sinai Heart Institute stem cell researchers led by Eduardo Marbán, M.D., Ph.D. has been awarded a four-year, $5.5 million grant from the California Institute of Regenerative Medicine (CIRM) to fund research leading to clinical trials of new treatments for heart attack patients.
Dendreon Corporation today announced that it has completed the submission of the post-approval supplement to the PROVENGE® (sipuleucel-T) Biologics License Application for the Morris Plains, New Jersey manufacturing facility. Dendreon is requesting licensure for an additional 36 workstations to manufacture PROVENGE. The standard U.S. Food and Drug Administration (FDA) review for a post-approval supplement to a Biologics License Application is typically four months.
To evaluate and understand the adherence to public health actions recommended by the government, a team in Norway undertook a study funded in part by the Norwegian Research Council's Centres of Excellence Funding Scheme and by the project: A realtime analytical pipeline for preparedness, planning, and response during the COVID-19 pandemic in Norway.
Can cancer patients tap into a certain kind of hope that is often overlooked but incredibly therapeutic and healing? Research by University Distinguished Professor of Marketing Leonard Berry of Texas A&M University's Mays Business School suggests clinicians can help patients tap into this kind of hope.
› Verified 3 days ago
| Entity Name | Wentworth Douglass Physician Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447352430 PECOS PAC ID: 5496749848 Enrollment ID: O20040409000433 |
News Archive
Scientists at Washington University School of Medicine in St. Louis have shown that a protein may help prevent the kind of brain damage that occurs in babies with cerebral palsy.
A team of Cedars-Sinai Heart Institute stem cell researchers led by Eduardo Marbán, M.D., Ph.D. has been awarded a four-year, $5.5 million grant from the California Institute of Regenerative Medicine (CIRM) to fund research leading to clinical trials of new treatments for heart attack patients.
Dendreon Corporation today announced that it has completed the submission of the post-approval supplement to the PROVENGE® (sipuleucel-T) Biologics License Application for the Morris Plains, New Jersey manufacturing facility. Dendreon is requesting licensure for an additional 36 workstations to manufacture PROVENGE. The standard U.S. Food and Drug Administration (FDA) review for a post-approval supplement to a Biologics License Application is typically four months.
To evaluate and understand the adherence to public health actions recommended by the government, a team in Norway undertook a study funded in part by the Norwegian Research Council's Centres of Excellence Funding Scheme and by the project: A realtime analytical pipeline for preparedness, planning, and response during the COVID-19 pandemic in Norway.
Can cancer patients tap into a certain kind of hope that is often overlooked but incredibly therapeutic and healing? Research by University Distinguished Professor of Marketing Leonard Berry of Texas A&M University's Mays Business School suggests clinicians can help patients tap into this kind of hope.
› Verified 3 days ago
| Entity Name | Icon Anesthesia Services Of New England Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629583323 PECOS PAC ID: 2668732041 Enrollment ID: O20210805001349 |
News Archive
Scientists at Washington University School of Medicine in St. Louis have shown that a protein may help prevent the kind of brain damage that occurs in babies with cerebral palsy.
A team of Cedars-Sinai Heart Institute stem cell researchers led by Eduardo Marbán, M.D., Ph.D. has been awarded a four-year, $5.5 million grant from the California Institute of Regenerative Medicine (CIRM) to fund research leading to clinical trials of new treatments for heart attack patients.
Dendreon Corporation today announced that it has completed the submission of the post-approval supplement to the PROVENGE® (sipuleucel-T) Biologics License Application for the Morris Plains, New Jersey manufacturing facility. Dendreon is requesting licensure for an additional 36 workstations to manufacture PROVENGE. The standard U.S. Food and Drug Administration (FDA) review for a post-approval supplement to a Biologics License Application is typically four months.
To evaluate and understand the adherence to public health actions recommended by the government, a team in Norway undertook a study funded in part by the Norwegian Research Council's Centres of Excellence Funding Scheme and by the project: A realtime analytical pipeline for preparedness, planning, and response during the COVID-19 pandemic in Norway.
Can cancer patients tap into a certain kind of hope that is often overlooked but incredibly therapeutic and healing? Research by University Distinguished Professor of Marketing Leonard Berry of Texas A&M University's Mays Business School suggests clinicians can help patients tap into this kind of hope.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Augustus Jarrett, MD 789 Central Ave, Dover, NH 03820-2526 Ph: (603) 609-6819 | Dr Robert Augustus Jarrett, MD 789 Central Ave, Dover, NH 03820-2526 Ph: (603) 609-6819 |
News Archive
Scientists at Washington University School of Medicine in St. Louis have shown that a protein may help prevent the kind of brain damage that occurs in babies with cerebral palsy.
A team of Cedars-Sinai Heart Institute stem cell researchers led by Eduardo Marbán, M.D., Ph.D. has been awarded a four-year, $5.5 million grant from the California Institute of Regenerative Medicine (CIRM) to fund research leading to clinical trials of new treatments for heart attack patients.
Dendreon Corporation today announced that it has completed the submission of the post-approval supplement to the PROVENGE® (sipuleucel-T) Biologics License Application for the Morris Plains, New Jersey manufacturing facility. Dendreon is requesting licensure for an additional 36 workstations to manufacture PROVENGE. The standard U.S. Food and Drug Administration (FDA) review for a post-approval supplement to a Biologics License Application is typically four months.
To evaluate and understand the adherence to public health actions recommended by the government, a team in Norway undertook a study funded in part by the Norwegian Research Council's Centres of Excellence Funding Scheme and by the project: A realtime analytical pipeline for preparedness, planning, and response during the COVID-19 pandemic in Norway.
Can cancer patients tap into a certain kind of hope that is often overlooked but incredibly therapeutic and healing? Research by University Distinguished Professor of Marketing Leonard Berry of Texas A&M University's Mays Business School suggests clinicians can help patients tap into this kind of hope.
› Verified 3 days ago
Dr. Dennis B. Thapa, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-609-6819 Fax: 603-609-6821 | |
Dr. Sargis Ohanyan, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-609-6819 | |
Dr. Ira Seth Lehrer, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-749-7246 Fax: 603-749-2453 | |
James M Mckenna, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 789 Central Ave, Wentworth Douglass Hospital, Dover, NH 03820 Phone: 603-749-7246 Fax: 603-749-2453 | |
Dr. Robert F. O'donnell, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-742-5252 | |
Dr. Christopher John Curatolo, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-742-5252 | |
Thomas Zouki, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-609-6819 Fax: 603-609-6821 |